ArticleEuropean journal of clinical pharmacology2026

Oral delivery of an ustekinumab biosimilar with bioavailability comparable to subcutaneous administration in healthy human participants.

Joshua T Myers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.